which companies make glp 1 drugs GLP-1 Receptor Agonist and Competitive Landscape The Rise of GLP-1 Medications

Hypoglycemia may occur in patients taking GLP-1 medications alongside insulin or sulfonylureas, though GLP-1 agonists alone carry minimal hypoglycemia risk due to their glucose-dependent mechanism

Figure 31: Photograph of Professor Bernard Thorens, credit Center for Integrative Genomics, University of Lausanne

[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Simo R, Liraglutide E LEAD-5 Met+SU Study Group

For those currently using or considering using GLP-1 medications, it can be confusing and frustrating to have multiple studies with differing and sometimes conflicting findings around a potential risk to eye health and vision

Four more gliptins, namely teneligliptin, anagliptin, omarigliptin, and trelagliptin are only approved in the Japanese and Korean markets